Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Vicky Roizen G"'
Autor:
María Del Pilar, Valdés A, Francisca, Schroeder H, Vicky, Roizen G, Juan, Honeyman M, Leonardo, Sánchez M
Publikováno v:
Revista medica de Chile. 134(3)
Psoriasis has a moderate or severe course in 25% of patients, requiring systemic therapy that is not always successful. Infliximab is a human-murine monoclonal anti tumor necrosis alpha (TNF-alpha) antibody. This mediator has a role in the pathogenes
Autor:
Francisca Schroeder H, Leonardo Sánchez M, María del Pilar Valdés A, Vicky Roizen G., Juan Honeyman M
Publikováno v:
Revista médica de Chile v.134 n.3 2006
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Background: Psoriasis has a moderate or severe course in 25% of patients, requiring systemic therapy that is not always successful. Infliximab is a human-murine monoclonal anti tumor necrosis alpha (TNF-a) antibody. This mediator has a role in the pa
Autor:
Carolina Valencia O, Vicky Roizen G, Beatriz Gottlieb B, Hernan Reyes M, Isabel Noemí H, Víctor Muñoz F
Publikováno v:
Revista chilena de pediatría v.66 n.6 1995
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Three different scredules of treatment for Giardia lamblia infection were evaluated in 416 children from poor neighbourhoods kindergarten schools by parasitologicai examination of fecal samples, In the first kindergarten (group I), children were only
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7764c2d19a69046463c07a2b6cb4bb3
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0370-41061995000600003
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0370-41061995000600003